Revenue: The sum of all revenue fields included for a company's operating activities.
Clearside Biomedical, Inc. (CLSD) had Revenue of $1.66M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$1.66M |
$-34.35M |
|
$0.15M |
|
$1.51M |
|
$30.55M |
|
$-28.88M |
|
$-5.47M |
|
$-34.35M |
|
$-34.35M |
|
$-34.35M |
|
$-34.35M |
|
$-34.35M |
|
$-34.35M |
|
$-28.88M |
|
$-29.00M |
|
73.80M |
|
73.80M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$21.27M |
|
$3.23M |
|
$3.85M |
|
$25.13M |
|
$4.79M |
|
-- |
|
$59.19M |
|
$63.98M |
|
$-38.85M |
|
$-38.85M |
|
$-38.85M |
|
76.58M |
|
| Cash Flow Statement Financials | |
$-24.70M |
|
$-0.64M |
|
$16.44M |
|
$28.92M |
|
$20.02M |
|
$-8.90M |
|
$4.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
91.05% |
|
-1735.70% |
|
-1735.70% |
|
-1742.49% |
|
-2064.42% |
|
-2064.42% |
|
$-25.68M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
3.28 |
|
111.21 |
|
88.41% |
|
88.41% |
|
-136.72% |
|
88.41% |
|
$-0.51 |
|
$-0.35 |
|
$-0.33 |
|